293 related articles for article (PubMed ID: 31791266)
1. Correlation of prechemotherapy urinary megalin ectodomain (A-megalin) levels with the development of cisplatin-induced nephrotoxicity: a prospective observational study.
Shoji S; Hosojima M; Kabasawa H; Kondo R; Miura S; Watanabe S; Aoki N; Kaseda R; Kuwahara S; Tanabe N; Hirayama Y; Narita I; Kikuchi T; Kagamu H; Saito A
BMC Cancer; 2019 Dec; 19(1):1170. PubMed ID: 31791266
[TBL] [Abstract][Full Text] [Related]
2. The endocytosis receptor megalin: From bench to bedside.
Goto S; Hosojima M; Kabasawa H; Saito A
Int J Biochem Cell Biol; 2023 Apr; 157():106393. PubMed ID: 36863658
[TBL] [Abstract][Full Text] [Related]
3. Early prediction of cisplatin-induced nephrotoxicity by urinary vanin-1 in patients with urothelial carcinoma.
Hosohata K; Washino S; Kubo T; Natsui S; Fujisaki A; Kurokawa S; Ando H; Fujimura A; Morita T
Toxicology; 2016 Jun; 359-360():71-5. PubMed ID: 27317936
[TBL] [Abstract][Full Text] [Related]
4. Significance of urinary full-length and ectodomain forms of megalin in patients with type 2 diabetes.
Ogasawara S; Hosojima M; Kaseda R; Kabasawa H; Yamamoto-Kabasawa K; Kurosawa H; Sato H; Iino N; Takeda T; Suzuki Y; Narita I; Yamagata K; Tomino Y; Gejyo F; Hirayama Y; Sekine S; Saito A
Diabetes Care; 2012 May; 35(5):1112-8. PubMed ID: 22410816
[TBL] [Abstract][Full Text] [Related]
5. Urinary protein biomarkers of kidney injury in patients receiving cisplatin chemotherapy.
George B; Joy MS; Aleksunes LM
Exp Biol Med (Maywood); 2018 Feb; 243(3):272-282. PubMed ID: 29231123
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomic Variants May Influence the Urinary Excretion of Novel Kidney Injury Biomarkers in Patients Receiving Cisplatin.
Chang C; Hu Y; Hogan SL; Mercke N; Gomez M; O'Bryant C; Bowles DW; George B; Wen X; Aleksunes LM; Joy MS
Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28640195
[TBL] [Abstract][Full Text] [Related]
7. Urinary Iron Excretion is Associated with Urinary Full-Length Megalin and Renal Oxidative Stress in Chronic Kidney Disease.
Nakatani S; Nakatani A; Ishimura E; Toi N; Tsuda A; Mori K; Emoto M; Hirayama Y; Saito A; Inaba M
Kidney Blood Press Res; 2018; 43(2):458-470. PubMed ID: 29590662
[TBL] [Abstract][Full Text] [Related]
8. Nephrotoxicity of cisplatin combination chemotherapy in thoracic malignancy patients with CKD risk factors.
Sato K; Watanabe S; Ohtsubo A; Shoji S; Ishikawa D; Tanaka T; Nozaki K; Kondo R; Okajima M; Miura S; Tanaka J; Sakagami T; Koya T; Kagamu H; Yoshizawa H; Narita I
BMC Cancer; 2016 Mar; 16():222. PubMed ID: 26979596
[TBL] [Abstract][Full Text] [Related]
9. Cadmium Complexed with β2-Microglubulin, Albumin and Lipocalin-2 rather than Metallothionein Cause Megalin:Cubilin Dependent Toxicity of the Renal Proximal Tubule.
Fels J; Scharner B; Zarbock R; Zavala Guevara IP; Lee WK; Barbier OC; Thévenod F
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31091675
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Renal Outcomes after Cisplatin Treatment.
Latcha S; Jaimes EA; Patil S; Glezerman IG; Mehta S; Flombaum CD
Clin J Am Soc Nephrol; 2016 Jul; 11(7):1173-1179. PubMed ID: 27073199
[TBL] [Abstract][Full Text] [Related]
11. Urine ratio of neutrophil gelatinase-associated lipocalin to creatinine as a marker for early detection of cisplatin-associated nephrotoxicity.
Shahbazi F; Sadighi S; Dashti-Khavidaki S; Shahi F; Mirzania M
Iran J Kidney Dis; 2015 Jul; 9(4):306-10. PubMed ID: 26174458
[TBL] [Abstract][Full Text] [Related]
12. Absence of effect of SLC22A2 genotype on cisplatin-induced nephrotoxicity in oesophageal cancer patients receiving cisplatin and 5-fluorouracil: report of results discordant with those of earlier studies.
Hinai Y; Motoyama S; Niioka T; Miura M
J Clin Pharm Ther; 2013 Dec; 38(6):498-503. PubMed ID: 24102360
[TBL] [Abstract][Full Text] [Related]
13. Urinary A- and C-megalin predict progression of diabetic kidney disease: an exploratory retrospective cohort study.
Iida T; Hosojima M; Kabasawa H; Yamamoto-Kabasawa K; Goto S; Tanaka T; Kitamura N; Nakada M; Itoh S; Ogasawara S; Kaseda R; Suzuki Y; Narita I; Saito A
J Diabetes Complications; 2022 Nov; 36(11):108312. PubMed ID: 36228564
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin nephrotoxicity is not detected by urinary cell-cycle arrest biomarkers in lung cancer patients.
Toprak Z; Cebeci E; Helvaci SA; Toprak ID; Kutlu Y; Sakin A; Tukek T
Int Urol Nephrol; 2017 Jun; 49(6):1041-1047. PubMed ID: 28255639
[TBL] [Abstract][Full Text] [Related]
15. Megalin Blockade with Cilastatin Suppresses Drug-Induced Nephrotoxicity.
Hori Y; Aoki N; Kuwahara S; Hosojima M; Kaseda R; Goto S; Iida T; De S; Kabasawa H; Kaneko R; Aoki H; Tanabe Y; Kagamu H; Narita I; Kikuchi T; Saito A
J Am Soc Nephrol; 2017 Jun; 28(6):1783-1791. PubMed ID: 28052987
[TBL] [Abstract][Full Text] [Related]
16. Identification of urinary candidate biomarkers of cisplatin-induced nephrotoxicity in patients with carcinoma.
Jiang W; Ma T; Zhang C; Tang X; Xu Q; Meng X; Ma T
J Proteomics; 2020 Jan; 210():103533. PubMed ID: 31629959
[TBL] [Abstract][Full Text] [Related]
17. Understanding the Risk Factors and Long-Term Consequences of Cisplatin-Associated Acute Kidney Injury: An Observational Cohort Study.
Bhat ZY; Cadnapaphornchai P; Ginsburg K; Sivagnanam M; Chopra S; Treadway CK; Lin HS; Yoo G; Sukari A; Doshi MD
PLoS One; 2015; 10(11):e0142225. PubMed ID: 26556481
[TBL] [Abstract][Full Text] [Related]
18. Renal uptake of 99mTc-dimercaptosuccinic acid is dependent on normal proximal tubule receptor-mediated endocytosis.
Weyer K; Nielsen R; Petersen SV; Christensen EI; Rehling M; Birn H
J Nucl Med; 2013 Jan; 54(1):159-65. PubMed ID: 23232279
[TBL] [Abstract][Full Text] [Related]
19. Identification of urinary miRNA biomarkers for detecting cisplatin-induced proximal tubular injury in rats.
Kanki M; Moriguchi A; Sasaki D; Mitori H; Yamada A; Unami A; Miyamae Y
Toxicology; 2014 Oct; 324():158-68. PubMed ID: 24863737
[TBL] [Abstract][Full Text] [Related]
20. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury.
Mishra J; Ma Q; Prada A; Mitsnefes M; Zahedi K; Yang J; Barasch J; Devarajan P
J Am Soc Nephrol; 2003 Oct; 14(10):2534-43. PubMed ID: 14514731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
